The reporter learned from the Cyberspace Administration of China that recently, the Cyberspace Administration of China, together with the National Healthcare Security Administration, has been deeply cracking down on online false and untrue information related to centralized procurement of pharmaceuticals, and has lawfully and contractually dealt with a batch of accounts that stigmatize centralized procurement, create anxiety, and mislead the public. On the 5th, the Cyberspace Administration of China reported some typical cases. Fabricating false information and stigmatizing the policy of centralized procurement. To attract traffic, fabricate false information about the poor quality of drugs and consumables for centralized procurement, or post secondary processed videos related to centralized procurement collected online. The accounts involved have been dealt with in accordance with the law and the agreement. Stirring social emotions and creating public anxiety. Distortion national policies, fabricate false information, and incite netizens to oppose original research drugs and generic drugs. Some of the accounts are designed to create public anxiety about drug use, guide the public to purchase relevant health products, high-end medical insurance, or induce the public to purchase drugs on specific Internet platforms. The accounts involved have been dealt with in accordance with the law and the agreement. Intentionally associating non centralized products with centralized procurement and misleading the public. In order to attract attention and attract traffic from centralized procurement, posts claiming that some medical equipment such as medical gloves, infusion bags, and indwelling needles have poor quality, but the actual products reflected are not centralized procurement products, which undermines the credibility of centralized procurement. The accounts involved have been dealt with in accordance with the law and the agreement. (New Society)